Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (1-10 of 333) with videos related to

Pageof 34
Sort By:
Multiple Sclerosis and Related Disorders|December 10, 2020
Effect size - one size doesn't fit allGary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Evidence of treatment benefit: is seeing believing or obfuscation by statistics?Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2023
Imposter clinical trials or answering questions with observational dataGary Cutter
Multiple Sclerosis and Related Disorders|November 13, 2019
EFFECT size or statistical significance, where to put your moneyGary Cutter
Neurology|November 12, 2003
Statistical issues in neutralizing antibodiesGary Cutter
Contemporary Clinical Trials|July 1, 2008
Bayesian interim analysis in clinical trialsXiao Zhang, Gary Cutter
Handbook of Clinical Neurology|February 11, 2014
Clinical trials in multiple sclerosisGary Cutter, Ludwig Kappos
American Journal of Public Health|June 27, 2002
Mammography screening and differences in stage of disease by race/ethnicityJillian Jacobellis, Gary Cutter
Annals of the New York Academy of Sciences|June 24, 2008
Rules of evidence for clinical trials: the science of finding the truth?Gary Cutter, Inmaculada Aban
Annals of Neurology|July 26, 2011
Got milk?Gary Cutter, Amber Salter
Pageof 34

Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
Multiple Sclerosis and Related Disorders|December 10, 2020
Effect size - one size doesn't fit allGary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Evidence of treatment benefit: is seeing believing or obfuscation by statistics?Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2023
Imposter clinical trials or answering questions with observational dataGary Cutter
Multiple Sclerosis and Related Disorders|November 13, 2019
EFFECT size or statistical significance, where to put your moneyGary Cutter
Neurology|November 12, 2003
Statistical issues in neutralizing antibodiesGary Cutter
Contemporary Clinical Trials|July 1, 2008
Bayesian interim analysis in clinical trialsXiao Zhang, Gary Cutter
Handbook of Clinical Neurology|February 11, 2014
Clinical trials in multiple sclerosisGary Cutter, Ludwig Kappos
American Journal of Public Health|June 27, 2002
Mammography screening and differences in stage of disease by race/ethnicityJillian Jacobellis, Gary Cutter
Annals of the New York Academy of Sciences|June 24, 2008
Rules of evidence for clinical trials: the science of finding the truth?Gary Cutter, Inmaculada Aban
Annals of Neurology|July 26, 2011
Got milk?Gary Cutter, Amber Salter
Pageof 34